Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
We identified an autosomal recessive infantile-onset symptomatic epilepsy syndrome associated with developmental stagnation and blindness. Assuming a founder effect in a large Old Order Amish pedigree, we carried out a genome-wide screen for linkage and identified a single region of homozygosity on chromosome 2p12-p11.2 spanning 5.1 cM (maximum lod score of 6.84). We sequenced genes in the region and identified a nonsense mutation in SIAT9, which is predicted to result in the premature termination of the GM3 synthase enzyme (also called lactosylceramide alpha-2,3 sialyltransferase). GM3 synthase is a member of the sialyltransferase family and catalyzes the initial step in the biosynthesis of most complex gangliosides from lactosylceramide. Biochemical analysis of plasma glycosphingolipids confirmed that affected individuals lack GM3 synthase activity, as marked by a complete lack of GM3 ganglioside and its biosynthetic derivatives and an increase in lactosylceramide and its alternative derivatives. Although the relationship between defects in ganglioside catabolism and a range of lysosomal storage diseases is well documented, this is the first report, to our knowledge, of a disruption of ganglioside biosynthesis associated with human disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Munro, S. (2003) · Cell · doi:10.1016/s0092-8674(03)00882-1 · Cited by 1,514
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Mice Expressing Only Monosialoganglioside GM3 Exhibit Lethal Audiogenic Seizures
Kawai, H., Allende, M. L., Wada, R., Kono, M., Sango, K., Deng, C., Miyakawa, T., Crawley, J. N., Werth, N., Bierfreund, U., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000847200 · Cited by 227
Gangliosides as modulators of cell function
Zeller, C. B., & Marchase, R. B. (1992) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1992.262.6.c1341 · Cited by 208
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Neville, D. C. A., Coquard, V., Priestman, D. A., te Vruchte, D. J. M., Sillence, D. J., Dwek, R. A., Platt, F. M., & Butters, T. D. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.03.051 · Cited by 178
Self-citationTraveling for the glycosphingolipid path
Hakomori, S.-I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011086929064 · Cited by 178
Wraith, J. E. (2002) · Seminars in Neonatology · doi:10.1053/siny.2001.0088 · Cited by 166
Refractory Skin Injury in Complex Knock-out Mice Expressing Only the GM3 Ganglioside
Inoue, M., Fujii, Y., Furukawa, K., Okada, M., Okumura, K., Hayakawa, T., Furukawa, K., & Sugiura, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201631200 · Cited by 107
Glycosphingolipid functions: insights from engineered mouse models
Proia, R. L. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1268 · Cited by 84
Cited by
Items 301–389 of 389
Zeng, M., Zhuang, H., Zhao, S., Chammas, R. J., & Chen, Y. (2026) · Biomolecules · doi:10.3390/biom16030464 · Cited by 4
GM3 synthase deficiency increases brain glucose metabolism in mice
Bharathi, S. S., Zhang, B. B., Paul, E., Zhang, Y., Schmidt, A. V., Fowler, B., Wu, Y. L., Tiemeyer, M., Inamori, K., Inokuchi, J., et al. (2022) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2022.10.006 · Cited by 4
Sun, C. Q., Hubl, U., Hoefakker, P., Vasudevamurthy, M. K., & Johnson, K. D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094206 · Cited by 4
Popa, I., Therville, N., Carpentier, S., Levade, T., Cuvillier, O., & Portoukalian, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019974 · Cited by 5
Congenital Disorders of Glycosylation
Sosicka, P., Ng, B. G., & Freeze, H. H. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819475-1.00013-4 · Cited by 5
Glycolipid Antigens in Neural Stem Cells
Itokazu, Y., & Yu, R. K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800781-5.00008-6 · Cited by 5
Visual Function in Mice Lacking GM3 Synthase
Hiraoka, M., Ohkawa, E., Abe, A., Murata, M., Go, S., Inokuchi, J., & Ohguro, H. (2019) · Current Eye Research · doi:10.1080/02713683.2019.1576206 · Cited by 6
Monolayers of Carbohydrate-Containing Lipids at the Water- Air Interface
Nepal, B., & Stine, K. J. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.76440 · Cited by 6
Chiricozzi, E., Lunghi, G., Valsecchi, M., Carsana, E. V., Bassi, R., Biase, E. D., Dobi, D., Ciampa, M. G., Mauri, L., Aureli, M., et al. (2025) · Biomedicines · doi:10.3390/biomedicines13040843 · Cited by 4
From molecular mechanisms of glycosphingolipid function to bio-therapeutic applications
Saha, A., & Johannes, L. (2026) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-026-06186-1 · Cited by 3
Abid, R., Nisar, H., Chaudhary, S. U., Hamid, M., Sahibzada, K. I., Firdous, S., Mudassar, M., & Sadaf, S. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2024.2314751 · Cited by 4
Shishido, F., Uemura, S., Kashimura, M., & Inokuchi, J. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.07.006 · Cited by 5
Exposure to SARS-CoV-2 and Infantile Diseases
Kanduc, D. (2023) · Global Medical Genetics · doi:10.1055/s-0043-1768699 · Cited by 3
DANGO: An MS data annotation tool for glycolipidomics
Matsubara, M., Ishihara, M., Tiemeyer, M., Aoki, K., & Ranzinger, R. (2025) · BBA Advances · doi:10.1016/j.bbadva.2025.100161 · Cited by 3
Ceramide center stage in progressive myoclonus epilepsies
Boustany, R. (2014) · Annals of Neurology · doi:10.1002/ana.24228 · Cited by 3
Role of Gangliosides in Neurological Development and the Influence of Dietary Sources
Méndez‐Otero, R., Pimentel‐Coelho, P. M., Евгеньевич, У. С., & McJarrow, P. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-254-4_9 · Cited by 3
Wang, H., Nye, L., Puffenberger, E. G., & Morton, H. D. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.31852 · Cited by 3
Self-citationLipids, a Missing Link in Prion Propagation
Castilla, J., & Goñi, F. M. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.11.002 · Cited by 3
Synthesis and Bioassay of Neurogenically Potent Gangliosides DSG-A, Hp-s1 and Their Analogues
Shelke, G. B., Lih, Y., Liao, Y.-J., Liang, C.-W., Kuo, T., Ko, Y., & Luo, S. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00055 · Cited by 3
Whitman, C. M., Bond, M. R., & Kohler, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-008045382-8.00681-x · Cited by 5
Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases
Zhong, X., D’Antona, A. M., & Rouse, J. C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252211962 · Cited by 3
Gangliosides in Axon Stability and Regeneration
Schnaar, R. L. (2014) · Springer eBooks · doi:10.1007/978-4-431-54841-6_119 · Cited by 2
Introduction to Human Glycosylation Disorders
Freeze, H. H., & Eklund, E. A. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-373600-0.00017-2 · Cited by 3
Glycomics, Glycobiology, and Glyco-Medicine
Freeze, H. H., & Ng, B. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00015-x · Cited by 2
Freeze, H. H., Ng, B., & Patterson, M. C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-37101-8.00040-0 · Cited by 2
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-411573-6.00012-7 · Cited by 2
Kolyovska, V., Ivanova, S., Drenska, D., Maslarov, D. B., & Toshkova, R. A. (2021) · Biocell · doi:10.32604/biocell.2021.016250 · Cited by 2
Vaz, F. M., Wortmann, S. B., & Mochel, F. (2022) · Springer eBooks · doi:10.1007/978-3-030-67727-5_51 · Cited by 2
Neurological Consequences of Congenital Disorders of Glycosylation
Paprocka, J. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_8 · Cited by 2
Sialyltransferase Activity Assay for Ganglioside GM3 Synthase
Inamori, K., Nitta, T., Shishido, F., Watanabe, S., Ohno, I., & Inokuchi, J. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2910-9_9 · Cited by 2
Structure and function of mammalian sphingolipids in health and disease
Rabionet, M., Engel, R., & Sandhoff, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-95582-9.00016-4 · Cited by 5
Mammalian Glycan Biosynthesis: Building a Template for Biological Recognition
Meledeo, M. A., Paruchuri, V. D. P., Du, J., Wang, Z., & Yarema, K. J. (2011) · Wiley eBooks · doi:10.1002/9781118017586.ch1 · Cited by 2
Anti-inflammatory Role of GM1 and Other Gangliosides on MicrogliaPreprint
Sipione, S., Galleguillos, D., Wang, Q., Steinberg, N., Zaidi, A. K., Shrivastava, G., Dhami, K., Daskhan, G. C., Schmidt, E. N., Dworsky-Fried, Z., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-829456/v1 · Cited by 2
Galleguillos, D., Zhao, Y., Pan, B., Vandermeer, B., Zaidi, A. K., Hamarneh, Y. N. A., Sarna, J. R., Suchowersky, O., Curtis, J. M., & Sipione, S. (2025) · medRxiv · doi:10.1101/2025.03.21.25324430 · Cited by 2
Recessive diseases and founder genetics
Puffenberger, E. G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820140-4.00012-0 · Cited by 1
Functions of glycosphingolipids in the central nervous system
Guo, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16156-8.00005-5 · Cited by 1
Impaired docking and recycling of synaptic vesicles in inherited lysosomal sphingolipidoses
Zelada, D., Saldivia, N., Konjeti, A., Samano, S., Marshall, M. S., Rebiai, R., Sutter, P. A., Zurawski, Z., Simchuk, D., Muchiri, R. N., et al. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02560-x · Cited by 1
Montavoci, L., Dei, M., Caretti, A., Mariem, O. B., Eberini, I., Giaquinto, L., Falco, A. D., Matteis, M. A. D., Brunetti‐Pierri, N., & Trinchera, M. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101102 · Cited by 1
(2019) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.40447 · Cited by 1
Congenital Disorders of Glycosylation
Jaeken, J. (2006) · Springer eBooks · doi:10.1007/978-3-540-28785-8_41 · Cited by 1
Congenital Disorders of Glycosylation
Jones, M. A., & Hegde, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-19674-9_8 · Cited by 1
Gangliosides in Axon Stability and Regeneration
Schnaar, R. L. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_119-1 · Cited by 1
Gangliosides and Tumor-Associated Ganglioside (TAG) Modulate Receptor-Tyrosine Kinases (RTKs)
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5815-3_9 · Cited by 1
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5807-8_3 · Cited by 1
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5815-3_8 · Cited by 1
Boustany, R., Al-Shareef, I., & El-Haddad, S. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00109-9 · Cited by 3
Jennemann, R., Gröne, H., Wiegandt, H., & Sandhoff, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-30378-9_28 · Cited by 1
Inherited epilepsy linked to gangliosides
Rowan, A. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1602 · Cited by 1
Opálka, L., Schlicker, L., & Sandhoff, R. (2023) · Wiley eBooks · doi:10.1002/9783527836512.ch15 · Cited by 3
Conventional/Conditional Knockout Mice
Miyoshi, I., Okamura, T., Kasai, N., Kitmoto, T., Ichikawa, S., Osuka, S., & Hirabayashi, Y. (2006) · Springer eBooks · doi:10.1007/4-431-34200-1_34 · Cited by 1
Sialylated Gangliosides are Required for Plasma Membrane Organization and Neuronal FunctionPreprint
Barrow, H. G., Han, Z. Z., Nicholson, A. S., Strasser, S., Nash, D. A., Suberu, J., Antrobus, R., Vruchte, D. T., Priestman, D. A., Graham, S. C., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.18.712603 · Cited by 5
Self-citationRôle des sphingolipides dans la cancérogenèse : l'exemple de la maladie de Gaucher
Astudillo, L. M. (2016) · theses.fr (ABES) · doi:10.70675/fa7a5078z1170z48a0z81a7z05c9d8e7a135 · Cited by 1
Prenatal Diagnosis of Disorders of Lipid Metabolism
Humphries, S. E., Mole, S., & WINCHESTER, B. G. (2015) · Wiley eBooks · doi:10.1002/9781118981559.ch20
Paediatric neurology: clinical advances with low technology
Wiznitzer, M. (2005) · The Lancet Neurology · doi:10.1016/s1474-4422(05)70264-7
Self-citationXu, Y., Barnes, S., Sun, Y., & Grabowski, G. A. (2010)
Huang, Q. (2016) · EngagedScholarship @ Cleveland State University (Cleveland State University) · Cited by 1
Role of autophagy in GM1-mediated neuroprotection in Huntington's Disease
Schmelz, S. (2016) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r3sj1b59m · Cited by 1
Technologies to Elucidate Functions of Glycans
Furukawa, K., Ohmi, Y., Kondo, Y., Ohkawa, Y., Tajima, O., Furukawa, K., Honke, K., Inokuchi, J., Gu, J., Kadomatsu, K., et al. (2019) · Springer eBooks · doi:10.1007/978-981-13-5856-2_4
Furukawa, K., Ohmi, Y., Yesmin, F., Tajima, O., Kondo, Y., Zhang, P., Hashimoto, N., Ohkawa, Y., Bhuiyan, R. H., & Furukawa, K. (2020)
Chemical labeling and analysis of sialoglycans
Cheng, B., & Chen, X. (2020) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2020-0207
Inherited Disorders of Glycosylation
Sparks, S. E. (2007) · Encyclopedia of Life Sciences · doi:10.1002/9780470015902.a0020230
横浜鶴見区のアスベスト健康リスク調査における「登録もれ」に関する考察
松田, 毅. (2011) · Institutional Repositories DataBase (IRDB) · doi:10.24546/81002782 · Cited by 1
Neural Functions of Glycolipids
Schnaar, R. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.14920-0
Prenatal Diagnosis of Disorders of Lipid Metabolism
Davison, J. E., Humphries, S. E., WINCHESTER, B. G., & Mole, S. (2021) · Wiley eBooks · doi:10.1002/9781119676980.ch25
Singer, H. S., Mink, J. W., Gilbert, D. L., & Jankovic, J. J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7506-9852-8.00011-4
Freeze, H. H., & Patterson, M. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0435-8.00035-4
Yang, H., Brown, R. H., Wang, D., Strauss, K. A., & Gao, G. (2022) · Research Square · doi:10.21203/rs.3.rs-1731386/v1
Introduction to the Complexity of Cell Surface and Tissue Matrix Glycoconjugates
BHAVANANDAN, V. P., & Gowda, D. C. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_1 · Cited by 1
Synthesis of O-Linked Glycoconjugates in the Nervous System
Inokuchi, J., Go, S., & Hirabayashi, Y. (2022) · Advances in neurobiology · doi:10.1007/978-3-031-12390-0_4
Carbohydrates and human glycosylation
Oommen, A. M., Gill, S. K., Joshi, L., & Cunningham, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-819655-7.00016-3
Decreasing ganglioside synthesis delays motor and cognitive symptom onset in Spg11 knockout micePreprint
Fortier, M., Cauhapé, M., Buono, S., Becker, J., Menuet, A., Branchu, J., Ricca, I., Mero, S., Dorgham, K., Hachimi, K. H. E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.29.577736
Glycosphingolipids and central nervous system–related diseases
Guo, Z. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-16156-8.00007-9
Patterson, M. C., Ng, B. G., & Eklund, E. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-10944-7.00062-7
Disorders in sialic acid metabolism and sialylation pathway
Sun, X. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.124141
Kary, S. A. (2009) · KU ScholarWorks (The University of Kansas) · Cited by 1
Dodge, J. C., Tamsett, T. J., Treleaven, C. M., Taksir, T. V., Piepenhagen, P. A., Sardi, S. P., Cheng, S. H., & Shihabuddin, L. S. (2022) · Figshare · doi:10.6084/m9.figshare.19106114
Associations of lipids with diseases in large cohort studies and randomized trials
Kaur, R. P., & Palagati, K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-19116-9.00040-3
Laaraje, A., Radi, A., Ourrai, A., Hassani, A., & Abilkassem, R. (2026) · Gene Reports · doi:10.1016/j.genrep.2026.102428
Leucine-rich glioma inactivated 1 is a ganglioside-binding proteinPreprint
Debreux, K., Lévêque, C., Azzaz, F., Sangiardi, M., Irani, S. R., SEAGAR, M. J., Fantini, J., & Far, O. E. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.05.703988
Analyses structurales et métaboliques de la sialylation des vertébrés
Vanbeselaere, J. (2013) · theses.fr (ABES) · doi:10.70675/f5ca88c1z90fdz4a02z94f0z2d244d6dbf4b · Cited by 1
Synthèse de nouveaux phosphinosucres et pseudo-disaccharides à activité anticancéreuse
Babouri, R. (2016) · theses.fr (ABES) · doi:10.70675/5d7edc07z5048z4f15zb25az6f7b97a3f9f7
Inborn Errors of Metabolism and Other Genetic Disorders with Features of Neonatal Encephalopathy
Enns, G. M. (2026) · Cambridge University Press eBooks · doi:10.1017/9781009418034.036
Leucine‐rich glioma inactivated 1 ( LGI1 ) is a ganglioside‐binding protein
Debreux, K., Lévêque, C., Azzaz, F., Sangiardi, M., Irani, S. R., SEAGAR, M. J., Fantini, J., & Far, O. E. (2026) · FEBS Letters · doi:10.1002/1873-3468.70465
Roles of sialoglycans in vertebrate development
Hildebrandt, H., & Münster-Kühnel, A. K. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113650 · Cited by 1
Disorders of Phospholipid and Glycosphingolipid Synthesis
Lamari, F., Sedel, F., & Saudubray, J. (2011) · Springer eBooks · doi:10.1007/978-3-642-15720-2_35
Metadata
- Authors
- Simpson, M. A., Cross, H., Proukakis, C., Priestman, D. A., Neville, D. C. A., Reinkensmeier, G., Wang, H., Wiznitzer, M., Gurtz, K., Verganelaki, A., Pryde, A., Patton, M. A., Dwek, R. A., Butters, T. D., Platt, F. M., & Crosby, A. H.
- Affiliations
- University of London (GB)
- University of Arizona (US)
- University of Oxford (GB)
- Rainbow Babies & Children's Hospital (US)
- Corresponding author
- Crosby, Andrew H
- ORCID
- Venue
- Nature Genetics
- Published
- 2004-10-24
- Volume
- 36
- Issue
- 11
- Pages
- 1225-1229
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2161292836
- Cited by
- 389
- References
- 22
- Citations by year
- 2026: 10 · 2025: 11 · 2024: 17 · 2023: 20 · 2022: 25 · 2021: 18 · 2020: 25 · 2019: 15 · 2018: 29 · 2017: 11 · 2016: 19 · 2015: 16 · 2014: 27 · 2013: 19 · 2012: 18
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Research to Prevent Blindness
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- GM3 synthase, loss-of-function mutations, autosomal recessive inheritance, founder effect, Old Order Amish, ganglioside biosynthesis, GM3 ganglioside, lactosylceramide, glycosphingolipids, blindness, sialyltransferase, linkage mapping
- MeSH terms
- Blindness, Developmental Disabilities, Chromosomes, Human, Pair 2, Epilepsy, Female, G(M3) Ganglioside, Genes, Recessive, Glycosphingolipids, Humans, Infant, Infant, Newborn, Male, Pedigree, Sialyltransferases, Syndrome, Codon, Nonsense, Founder Effect
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.